| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 203 companies in the Health Care Equipment & Supplies industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 31, 2022 | RBOT Vicarious Surgical Inc. | Liang Philip45 | Director | Sell | 28,000 | $4.24 | $118,652.80 | -2.2% | -11.6% | -52.1% | |
| May 31, 2022 | SONX Sonendo, Inc. | Bergheim Bjarne | President And CEO | Buy | 6,452 | $2.74 | $17,646.87 | +0.7% | - | - | |
| May 31, 2022 | EW Edwards Lifesciences Corp | Zovighian Bernard J55 | Cvp, Tmtt | Sell | 9,000 | $100.83 | $907,488.90 | -22.6% | -10.4% | -16.5% | |
| May 31, 2022 | ECOR Electrocore, Inc. | Moody Trevor J | Director | Buy | 50,000 | $0.44 | $21,968.97 | +6.6% | +12.4% | -27.4% | |
| May 31, 2022 | NXGL Nexgel, Inc. | Drapczuk Adam E III62 | Chief Financial Officer | Buy | 20,000 | $1.61 | $32,172.00 | +133.3% | +4.8% | +62.1% | |
| May 31, 2022 | STIM Neuronetics, Inc. | Cannell Capital LLC69 | 10% Owner | Buy | 9,546 | $2.71 | $25,912.40 | - | +44.8% | +1.9% | |
| May 27, 2022 | RBOT Vicarious Surgical Inc. | Sachs Adam David84 | President And CEO | Sell | 11,329 | $4.06 | $46,005.94 | -0.9% | +2.2% | -46.8% | |
| May 27, 2022 | BLFS Biolife Solutions Inc | Mathew Aby J.68 | EVP &Chief Scientific Officer | Sell | 351 | $14.53 | $5,100.03 | -0.1% | +65.0% | +52.7% | |
| May 27, 2022 | BLFS Biolife Solutions Inc | Wichterman Troy60 | Chief Financial Officer | Sell | 43 | $14.53 | $624.79 | - | +65.0% | +52.7% | |
| May 27, 2022 | BLFS Biolife Solutions Inc | Rice Michael72 | CEO | Sell | 749 | $14.53 | $10,882.97 | -0.2% | +65.0% | +52.7% | |
| May 27, 2022 | BLFS Biolife Solutions Inc | Foster Karen A.68 | Chief Quality Officer | Sell | 174 | $14.53 | $2,528.22 | -0.2% | +65.0% | +52.7% | |
| May 27, 2022 | TELA Tela Bio, Inc. | Ew Healthcare Partners Fund 2, L.P.57 | See Footnote 2 | Buy | 15,000 | $7.11 | $106,700.00 | +0.1% | +15.5% | +49.7% | |
| May 26, 2022 | EW Edwards Lifesciences Corp | Chopra Daveen59 | Cvp, Surgical Structural Heart | Sell | 1,000 | $98.31 | $98,311.80 | -4.8% | -3.7% | -16.8% | |
| May 26, 2022 | RPID Rapid Micro Biosystems, Inc. | Kennedy Lewis Management LP | 10% Owner | Buy | 49,883 | $4.59 | $228,874.02 | +0.5% | -31.7% | -78.5% | |
| May 26, 2022 | STXS Stereotaxis, Inc. | Isaac Paul J78 | Director, See Remarks | Buy | 14,300 | $1.82 | $25,967.00 | +0.3% | +21.0% | +13.8% | |
| May 26, 2022 | TMCI Treace Medical Concepts, Inc. | Treace James T53 | - | Sell | 50,000 | $15.52 | $775,857.60 | -1.8% | +24.0% | +63.6% | |
| May 25, 2022 | SONX Sonendo, Inc. | Bergheim Bjarne | President And CEO | Buy | 11,748 | $2.60 | $30,550.67 | +1.3% | - | - | |
| May 25, 2022 | RGEN Repligen Corp | Dawes Karen A63 | Director | Sell | 14,715 | $150.51 | $2,214,819.39 | -3.5% | +45.3% | +8.9% | |
| May 25, 2022 | AHCO Adapthealth Corp. | Skyknight Capital Fund Ii, L.P.53 | Director | Buy | 200 | $17.50 | $3,500.00 | - | +16.4% | -40.8% | |
| May 25, 2022 | MLSS Milestone Scientific Inc. | Goldman Neal I79 | Director | Buy | 13,208 | $0.89 | $11,755.12 | +1.2% | +4.9% | +5.6% | |
| May 25, 2022 | SONX Sonendo, Inc. | Pudipeddi Vamsi Mohan Raj | Director | Buy | 45,000 | $2.65 | $119,292.09 | +44.4% | - | - | |
| May 25, 2022 | RVP Retractable Technologies Inc | Leonard Braden Michael60 | - | Buy | 63,474 | $3.98 | $252,898.42 | +0.9% | -26.5% | -69.5% | |
| May 25, 2022 | STIM Neuronetics, Inc. | Cannell Capital LLC69 | 10% Owner | Buy | 36,123 | $2.44 | $88,189.26 | +0.4% | +74.7% | +14.1% | |
| May 24, 2022 | DXCM Dexcom Inc | Pacelli Steven Robert57 | EVP Managing Director Dexcom V | Sell | 250 | $296.33 | $74,082.50 | -0.7% | +17.0% | +62.1% | |
| May 24, 2022 | VERO Venus Concept Inc. | Hollmig Stanley Tyler | - | Buy | 40,000 | $0.64 | $25,720.00 | New | -42.9% | -75.7% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.